Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer

Yasmine Nadler, Robert L. Camp, Candice Schwartz, David L. Rimm, Harriet M. Kluger, Yuval KlugerClinical 2008 · DOI

Abstract

Aurora A expression defines a population of patients with decreased survival, whereas Aurora B expression does not, suggesting that Aurora A might be the preferred drug target in breast cancer. Aurora A expression in early-stage breast cancer may identify a subset of patients requiring more aggressive or pathway-targeted treatment. Prospective studies are needed to confirm the prognostic role of Aurora A as well as the predictive role of Aurora A expression in patients treated with Aurora A inhibitors.
BibTeX
@inproceedings{nadler2008expression,
  author = {Yasmine Nadler and Robert L. Camp and Candice Schwartz and David L. Rimm and Harriet M. Kluger and Yuval Kluger},
  title = {{Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer}},
  booktitle = {Clinical},
  year = {2008},
  doi = {10.1158/1078-0432.ccr-07-5268},
}

Loading related content...

Figure